FIELD: medicine, oncology. SUBSTANCE: invention relates to methods for treatment of localized and disseminated form of Ewing's sarcoma. Before onset of treatment bioptic material is taken in the patient from tumor wherein glucocorticoid receptors are assayed in tumor cytosol fraction and lactate dehydrogenase activity is determined in serum blood. In the case of lactate dehydrogenase activity exceeding physiological norm and in the presence of glucocorticoid receptors aminoglutethimide is used by oral route in the dose 60 mg, 2-4 times per a day. Method provides increasing duration and quality of life by the process stabilization, complete or partial regression of tumor and metastasis. EFFECT: enhanced effectiveness of treatment. 2 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING DISSEMINATED FORM OF OSTEOGENIC SARCOMA | 2000 |
|
RU2191006C2 |
METHOD OF TREATING BONE SARCOMAS IN CHILDREN AND ADOLESCENTS | 2004 |
|
RU2264214C1 |
COMBINED METHOD FOR TREATING DISSEMINATED STOMACH CANCER CASES | 2003 |
|
RU2270677C2 |
METHOD FOR PREDICTING METASTASES DEVELOPMENT OF OSTEOGENOUS SARCOMA INTO LUNGS | 1991 |
|
RU2067761C1 |
METHOD OF TREATING MALIGNANT RETROPERITONEAL TUMOURS IN CHILDREN | 2009 |
|
RU2420239C1 |
METHOD OF TREATING SPINE TUMOURS | 2014 |
|
RU2551622C1 |
METHOD OF TREATMENT OF PATIENTS WITH LOCAL NON-SMALL CELL LUNG CANCER | 2007 |
|
RU2361580C2 |
METHOD OF TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2010 |
|
RU2429032C1 |
METHOD OF MEDICINAL THERAPY OF DISSEMINATED MALIGNANT NEOPLASMS | 2007 |
|
RU2340355C1 |
METHOD FOR APPLYING COMBINED SKIN MELANOMA TREATMENT | 2006 |
|
RU2312687C1 |
Authors
Dates
2004-01-27—Published
2002-10-09—Filed